Understanding Steven Horwitz
Exploring Steven Horwitz reveals several interesting facts. ASH Meeting on Hematologic Maligancies speaker
Key Takeaways about Steven Horwitz
- September 2018: Brentuximab vedotin (ADCETRIS®) has recently been approved as a treatment for cutaneous lymphoma.
- "In the 25 years since I've been studying central banking and competitive alternatives, there's never been so much attention on the ...
- Does TCLF present opportunities unavailable at larger conferences? Interviewed at the 7th Annual T-cell Lymphoma Forum held ...
- What is the most important highlight from TCLF 2015? Interviewed at the 7th Annual T-cell Lymphoma Forum held January 29-31, ...
- Has there been anything presented at TCLF 2015 that has been surprising? Interviewed at the 7th Annual T-cell Lymphoma ...
Detailed Analysis of Steven Horwitz
Welcome Video by Dr. Interview with Steven Horwitz
What message do you have for young investigators thinking of attending future T-cell Lymphoma Forums? Interviewed at the 7th ...
Stay tuned for more updates related to Steven Horwitz.